GlaxoSmithKline plc (GSK)

980 Great West Road,
Brentford, TW8 9GS
United Kingdom,
+44 20 8047 5000

GlaxoSmithKline plc is a multinational pharmaceutical, biologics, vaccines and consumer healthcare company. GlaxoSmithKline was originally established in 1935 and is based in Brentford, England.

M&A Summary

Buy vs Sell

Year ≤ '13 '14 '15 '16 '17 '18 T
Buy (0.2/yr) # 23 - 1 - - - 24
vol $91.8B $190M $92.0B
Sell (0.6/yr) # 13 - 2 - 1 - 16
vol $6.0B $130M $6.1B

Top M&A Advisors

Financial Deals
Sign-up to View
Sign-up to View
Legal Deals
Sign-up to View
Sign-up to View
Sign-up to View

Deal Values

> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
TOTAL Sign-up to View
Largest SmithKline Beecham Ltd.
$75.7B (2000-01-17)
Sell # Total
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
Total Sign-up to View
Largest Lucozade Ribena Suntory Ltd.
$2.1B (2013-09-09)

According to our data here at Mergr, GlaxoSmithKline has acquired 24 companies, including 2 in the last 5 years. A total of 4 acquisitions came from private equity firms. It has also divested 16 assets.

GlaxoSmithKline’s largest acquisition to date was in 2000, when it acquired SmithKline Beecham for $75.7B. It’s largest disclosed sale occurred in 2013, when it sold Lucozade Ribena Suntory to Suntory Holdings for $2.1B. GlaxoSmithKline has acquired in 11 different US states, and 8 countries. The Company’s most targeted sectors include life science (80%) and medical products (13%).

When analyzing the life science sector as a whole, according to Mergr, in the last 3 years, there are 417 life science companies that have made at least 1 acquisition, 22 have acquired at least 5 companies, and 2 have acquired more than 10 companies. The most prolific strategic life science acquirer over the past 3 years is Eurofins Scientific SA, with 30 acquisitions. The most prolific private equity acquirer in the life science sector over the past 3 years is Ampersand Capital Partners with 5 platform acquisitions.

Join Mergr and gain access to GlaxoSmithKline’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.

What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
  • 3.4K Private Equity Firms
  • 118K M&A Transactions
  • 128K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 35K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.